(Q37542243)

English

Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).

scientific article published on June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study). (English)

1 reference

Europe PubMed Central

20 August 2017

0 references

demyelinating polyneuropathy

1 reference

based on heuristic

inferred from title

Björn Tackenberg

9

object named as

Björn Tackenberg

1 reference

Europe PubMed Central

20 August 2017

author name string

Jean-Marc Léger

1

1 reference

Europe PubMed Central

20 August 2017

Jan L De Bleecker

2

1 reference

Europe PubMed Central

20 August 2017

Claudia Sommer

3

1 reference

Europe PubMed Central

20 August 2017

Wim Robberecht

4

1 reference

Europe PubMed Central

20 August 2017

Mika Saarela

5

1 reference

Europe PubMed Central

20 August 2017

Jerzy Kamienowski

6

1 reference

Europe PubMed Central

20 August 2017

Zbigniew Stelmasiak

7

1 reference

Europe PubMed Central

20 August 2017

Orell Mielke

8

1 reference

Europe PubMed Central

20 August 2017

Amgad Shebl

10

1 reference

Europe PubMed Central

20 August 2017

Artur Bauhofer

11

1 reference

Europe PubMed Central

20 August 2017

Othmar Zenker

12

1 reference

Europe PubMed Central

20 August 2017

Ingemar S J Merkies

13

1 reference

Europe PubMed Central

20 August 2017

PRIMA study investigators

14

1 reference

Europe PubMed Central

20 August 2017

publication date

1 June 2013

1 reference

Europe PubMed Central

20 August 2017

Journal of the Peripheral Nervous System

1 reference

Europe PubMed Central

20 August 2017

18

1 reference

Europe PubMed Central

20 August 2017

2

1 reference

Europe PubMed Central

20 August 2017

130-140

1 reference

Europe PubMed Central

20 August 2017

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

23 August 2017

Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

23 August 2017

Incidence and prevalence of CIDP and the association of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

23 August 2017

Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

23 August 2017

Chronic inflammatory demyelinating polyneuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

23 August 2017

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

23 August 2017

Hemolysis upon intravenous immunoglobulin transfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

6 September 2017

Hematologic toxicities associated with intravenous immunoglobulin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

6 September 2017

Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

6 September 2017

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

14 September 2017

Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

14 September 2017

Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

14 September 2017

Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

25 June 2018

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

25 June 2018

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

25 June 2018

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

1 September 2018

131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Naarden, The Netherlands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

1 September 2018

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

1 September 2018

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910165

1 September 2018

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23781960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

151st ENMC international workshop: Inflammatory Neuropathy Consortium 13th-15th April 2007, Schiphol, The Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/23781960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23781960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The vigorimeter: for measurement of the strength of the hand and simulation testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/23781960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23781960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/JNS5.12017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37542243&oldid=2174220043"